Sleep-specific DBS Therapy in Parkinson's Disease
Palo Alto (17 mi)Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: N/A
Recruiting
Sponsor: University of Minnesota
No Placebo Group
Trial Summary
What is the purpose of this trial?Sleep-wake disturbances are a major factor associated with reduced quality of life of individuals with Parkinson's disease (PD), a progressive neurological disorder affecting millions of people in the U.S and worldwide. The brain mechanisms underlying these sleep disorders, and the effects of therapeutic interventions such as deep brain stimulation on sleep-related neuronal activity and sleep behavior, are not well understood. Results from this study will provide a better understanding of the brain circuitry involved in disordered sleep in PD and inform the development of targeted therapeutic interventions to treat sleep disorders in people with neurodegenerative disease.
Eligibility Criteria
Treatment Details
2Treatment groups
Experimental Treatment
Group I: ON DBS followed by OFF DBSExperimental Treatment1 Intervention
Group II: OFF DBS followed by ON DBSExperimental Treatment1 Intervention
Find a clinic near you
Research locations nearbySelect from list below to view details:
University Of MinnesotaMinneapolis, MN
Loading ...
Who is running the clinical trial?
University of MinnesotaLead Sponsor